Home

Biofil Chemicals & Pharmaceuticals Ltd PE Ratio

Image

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM

PE

163.6

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 163.6 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd changed from 10 on March 2020 to 137.2 on March 2024 . This represents a CAGR of 68.84% over 5 years.
  • The Latest Trading Price of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 54.54 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd

No data available

Company Fundamentals for Biofil Chemicals & Pharmaceuticals Ltd

Image

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM

Share Price

₹ 54.54

0.54 (1.00%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Biofil Chemicals & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Biofil Chemicals & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202554
13 Jan 202553.64
10 Jan 202555.98
09 Jan 202557.46
08 Jan 202558.64
07 Jan 202558.77
06 Jan 202556.35
03 Jan 202561.32
02 Jan 202562.33
01 Jan 202561.03

SWOT Analysis Of Biofil Chemicals & Pharmaceuticals Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Biofil Chemicals & Pharmaceuticals Ltd

Asset Value vs Market Value of Biofil Chemicals & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Biofil Chemicals & Pharmaceuticals Ltd87.86
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd Explained

``

87.86

Market cap

0

Earnings

163.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Biofil Chemicals & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Biofil Chemicals & Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd

No data available

* All values are in %

About Biofil Chemicals & Pharmaceuticals Ltd

  • Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products.
  • Later on, the Company was converted into a Public Limited Company on 7 May '92.
  • The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
  • It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations.
  • The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.

Biofil Chemicals & Pharmaceuticals Ltd News Hub

Biofil Chemicals & Pharmaceuticals standalone net profit declines 29.17% in the June 2024 quarter

Net profit of Biofil Chemicals & Pharmaceuticals declined 29.17% to Rs 0.17 crore in the quarter end

Read more

2024-08-14 00:00:00

Biofil Chemicals & Pharmaceuticals to table results

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1

Read more

2024-08-12 00:00:00

Biofil Chemicals & Pharmaceuticals AGM scheduled

Biofil Chemicals & Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa

Read more

2024-09-10 00:00:00

Biofil Chemicals & Pharmaceuticals to conduct board meeting

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1

Read more

2024-11-08 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Biofil Chemicals & Pharmaceuticals Ltd

What is the current PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd?

The Current PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 163.64 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd last year?

The PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd was 121.88 last year, now the PE ratio is 163.64, showing a year-on-year growth of 34.3%.

What does the PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 163.64. This ratio indicates that investors are willing to pay 163.64 times the earnings per share for each share of Biofil Chemicals & Pharmaceuticals Ltd.

What is the PE Ratio Growth of Biofil Chemicals & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd grew by 34.3% whereas, the EPS ratio grew by -90.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions